Upstream Bio, Inc.
UPB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $590 | $328 | $844 |
| - Cash | $72 | $45 | $71 | $326 |
| + Debt | $1 | $2 | $2 | $2 |
| Enterprise Value | – | $547 | $259 | $520 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -27.1% | 65.5% | -7.7% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 95.5% | 100% | 100% | 100% |
| EBITDA | -$34 | -$44 | -$32 | -$26 |
| % Margin | -4,936.6% | -4,728.4% | -5,648.4% | -4,285.3% |
| Net Income | -$34 | -$40 | -$27 | -$21 |
| % Margin | -4,941.1% | -4,265.3% | -4,818% | -3,465.3% |
| EPS Diluted | -0.63 | -0.74 | -0.51 | -0.41 |
| % Growth | 14.9% | -45.1% | -24.4% | – |
| Operating Cash Flow | -$22 | -$39 | -$41 | -$20 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$22 | -$39 | -$41 | -$20 |